Recent guidance and proposed rulemaking by CMS for the Medicare hospice program will require changes for Medicare Part D plans. The 340B drug discount program is currently in an unusual legal limbo keeping the government from publishing regulations. These rules are wanted by both supporters and critics of the program to provide clarity on such areas as patient definition, contract pharmacy and the definition of outpatient clinics.
It is anyone’s guess when the government will actually issue these regulations. The pharmaceutical industry is lobbying heavily against 340B in Washington. Drug companies want the program limited to uninsured patients only. Safety net hospitals argue this move would effectively derail the program and cause providers to cut services to the poor and/or look to local taxpayers to fill the funding gap.